1. Home
  2. KEN vs NVCR Comparison

KEN vs NVCR Comparison

Compare KEN & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEN
  • NVCR
  • Stock Information
  • Founded
  • KEN 2014
  • NVCR 2000
  • Country
  • KEN Singapore
  • NVCR Switzerland
  • Employees
  • KEN 344
  • NVCR N/A
  • Industry
  • KEN Electric Utilities: Central
  • NVCR Medical/Dental Instruments
  • Sector
  • KEN Utilities
  • NVCR Health Care
  • Exchange
  • KEN Nasdaq
  • NVCR Nasdaq
  • Market Cap
  • KEN 2.2B
  • NVCR 1.9B
  • IPO Year
  • KEN N/A
  • NVCR 2015
  • Fundamental
  • Price
  • KEN $43.78
  • NVCR $17.71
  • Analyst Decision
  • KEN
  • NVCR Buy
  • Analyst Count
  • KEN 0
  • NVCR 6
  • Target Price
  • KEN N/A
  • NVCR $32.83
  • AVG Volume (30 Days)
  • KEN 22.9K
  • NVCR 1.6M
  • Earning Date
  • KEN 05-28-2025
  • NVCR 07-24-2025
  • Dividend Yield
  • KEN 10.96%
  • NVCR N/A
  • EPS Growth
  • KEN N/A
  • NVCR N/A
  • EPS
  • KEN 11.35
  • NVCR N/A
  • Revenue
  • KEN $760,304,000.00
  • NVCR $621,711,000.00
  • Revenue This Year
  • KEN N/A
  • NVCR $5.56
  • Revenue Next Year
  • KEN N/A
  • NVCR $9.19
  • P/E Ratio
  • KEN $3.79
  • NVCR N/A
  • Revenue Growth
  • KEN 5.78
  • NVCR 18.27
  • 52 Week Low
  • KEN $23.31
  • NVCR $14.17
  • 52 Week High
  • KEN $43.88
  • NVCR $34.13
  • Technical
  • Relative Strength Index (RSI)
  • KEN 83.27
  • NVCR 51.32
  • Support Level
  • KEN $42.20
  • NVCR $17.53
  • Resistance Level
  • KEN $39.69
  • NVCR $18.70
  • Average True Range (ATR)
  • KEN 0.75
  • NVCR 0.72
  • MACD
  • KEN 0.55
  • NVCR 0.09
  • Stochastic Oscillator
  • KEN 98.93
  • NVCR 60.56

About KEN Kenon Holdings Ltd.

Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented businesses. The company's operating segments include OPC Power Plants, CPV Group, and ZIM. It generates maximum revenue from the OPC Power Plants segment, which generates and supplies electricity and energy in Israel. CPV Group is a limited partnership owned by OPC, which generates and supplies electricity and energy in the United States. Geographically, the company generates a majority of its revenue from Israel and the rest from the United States.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: